Skip to main content
Clinical Trials/JPRN-UMIN000041933
JPRN-UMIN000041933
Completed
未知

Exploratory trial of bodily sensation evaluation by test-food intake - Exploratory trial of bodily sensation evaluation by test-food intake

CPCC Company Limited0 sites50 target enrollmentOctober 1, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy female subjects
Sponsor
CPCC Company Limited
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 1, 2021
End Date
December 10, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
CPCC Company Limited

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Subjects with some kind of medical treatment continuously. 2\) Subjects taking steadily in the medicine and/or health\-specific/functional/health foods, which might affect the test results. 3\) Subjects who have been determined as a patient with the chronic fatigue syndrome (CFS), or subjects with severe fatigue just like the idiopathic chronic fatigue, judging from the principal/sub investigator's opinions. 4\) Subjects with some kind of medical treatment continuously. 5\) Subjects with atopic dermatitis, contact dermatitis and/or skin hypersensitivity. 6\) Subjects with excessive suntan, and/or some kind of work/sport outside for a long time. 7\) Subjects with some kind of specific care outside, and/or planning to receive the care during this trial. 8\) Pregnant, possibly pregnant, or lactating women. 9\) Subjects who have previous and/or current medical history of serious diseases in heart, liver, kidney and/or digestive organs. 10\) Subjects with excessive alcohol intake. 11\) Subjects with extremely irregular life rhythms, midnight work and/or irregular shift one. 12\) Subjects with previous medical history of drug and/or food allergy. 13\) Subjects who are now under the other clinical tests with some kind of medicines/foods, or took part in those tests within four weeks after this trial. 14\) Others who have been determined as ineligible for participation, according to the principal/sub investigator's opinions.

Outcomes

Primary Outcomes

Not specified

Similar Trials